Trials / Sponsors / C2N Diagnostics
C2N Diagnostics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease Alzheimers Disease | N/A | 2025-07-01 |
| Unknown | Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey Alzheimer Disease, Mild Cognitive Impairment, Dementia | — | 2023-11-15 |
| Completed | Quality Improvement PrecivityAD Clinician Survey (QUIP I) Alzheimer Disease, Mild Cognitive Impairment, Dementia | — | 2021-03-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Progressive Supranuclear Palsy | Phase 1 | 2015-07-01 |